Evidence map›Paper›PMID 27812163›Full record

ArticlePloS one2016

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.

Kerstin A Kessel, Sabrina Lettner, Carmen Kessel, Henning Bier, Tilo Biedermann, Helmut Friess, Peter Herrschbach, Jürgen E Gschwend, Bernhard Meyer, Christian Peschel and 4 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Oncology researchers' and clinicians' perceptions of complementary, alternative, and integrative medicine: an international, cross-sectional survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  8. Article
  9. Article
  10. Cancer patients' behaviors and attitudes toward natural health products.BMC complementary medicine and therapies · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kerstin A KesselDepartment of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Sabrina LettnerDepartment of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Carmen KesselDepartment of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Henning BierDepartment of Otorhinolaryngology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Tilo BiedermannDepartment of Dermatology and Allergy Biederstein, Technical University of Munich (TUM), Biedersteiner Straße 29, Munich, Germany.
Helmut FriessDepartment of Surgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Peter HerrschbachRoman-Herzog-Krebszentrum Comprehensive Cancer Center (RHCCC), Technical University of Munich (TUM), Trogerstraße 26, Munich, Germany.
Jürgen E GschwendDepartment of Urology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Bernhard MeyerDepartment of Neurosurgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Christian Peschel3rd Department of Internal Medicine, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Roland Schmid2nd Department of Internal Medicine, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Markus SchwaigerDepartment of Nuclear Medicine, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Klaus-Dietrich WolffDepartment of Oral and Maxillofacial Surgery, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Stephanie E CombsDepartment of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo understand if and which patients would be open-minded to Complementary and Alternative Medicine (CAM) use parallel to their oncological treatment. Moreover, we sought to determine which methods are most accepted and which are the primary motivators to use CAM.

methodsWe developed and anonymously conducted a questionnaire for patients in the oncology center (TU Munich). Questions focus on different CAM methods, previous experiences, and willingness to apply or use CAM when offered in a university-based setting.

resultsA total of 171 of 376 patients (37.4% women, 62.0% men, 0.6% unknown) participated. This corresponds to a return rate of 45%. Median age was 64 years (17-87 years). Of all participants, 15.2% used CAM during their oncological therapy; 32.7% have used it in the past. The majority (81.9%) was not using CAM during therapy; 55.5% have not used CAM in the past respectively. The analysis revealed a significant correlation between education and CAM use during therapy (r = 0.18; p = 0.02), and CAM use in the past (r = 0.17; p = 0.04). Of all patients using CAM during therapy, favored methods were food supplements (42.3%), vitamins/minerals (42.3%), massage (34.6%). Motivations are especially the reduction of side effect and stress, the positive effect of certain CAM-treatments on the immune system and tumor therapy. Results showed no difference between women and men. Most patients not having had any experience with CAM complain about the deficiency of information by their treating oncologist (31.4%) as well as missing treatment possibilities (54.3%).

conclusionSince many patients believe in study results demonstrating the efficacy of CAM, it stresses our task to develop innovative study protocols to investigate the outcomes of certain CAM on symptom reduction or other endpoints. Thus, prospective trials and innovative evidence-based treatment concepts to include CAM into high-end oncology is what patients demand and what a modern oncology center should offer.

Indexed as

Attitude of Health PersonnelAttitude to HealthAdolescentAdultAgedAged, 80 and overComplementary TherapiesDietary SupplementsFemaleHumansInternal MedicineMaleMassageMiddle AgedNeoplasmsOncology Service, HospitalVitamins

Identifiers

PMID27812163
PMCPMC5094772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.